HomeCTBO • OTCMKTS
add
Cantabio Pharmaceuticals Inc
Previous close
$1.01
Year range
$1.01 - $1.01
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2018info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.35M | 26.14% |
Net income | -2.01M | -80.89% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2018info | Y/Y change |
|---|---|---|
Cash and short-term investments | 109.43K | 239.04% |
Total assets | 109.43K | 226.42% |
Total liabilities | 1.98M | 123.41% |
Total equity | -1.87M | — |
Shares outstanding | 10.77K | — |
Price to book | -0.01 | — |
Return on assets | -1,179.44% | — |
Return on capital | 146.23% | — |
Cash Flow
Net change in cash
| (USD) | 2018info | Y/Y change |
|---|---|---|
Net income | -2.01M | -80.89% |
Cash from operations | -623.35K | 35.94% |
Cash from investing | — | — |
Cash from financing | 700.50K | -26.52% |
Net change in cash | 77.15K | 488.96% |
Free cash flow | -75.30K | 86.53% |
About
Founded
2009
Headquarters
Website
Employees
3
